World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
25353
World Ranking
15123
National Ranking
1395

Overview

Andrew D.J. Pearson is affiliated with the Royal Marsden NHS Foundation Trust in the United Kingdom. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with significant contributions to specialized subfields including Neurology, Molecular Biology, Pediatrics, Perinatology and Child Health, Oncology, and Cancer Research.

The scientist's work engages deeply with several main topics, notably:

  • Neuroblastoma Research and Treatments
  • Childhood Cancer Survivors' Quality of Life
  • Cancer therapeutics and mechanisms
  • Cancer, Hypoxia, and Metabolism
  • CAR-T cell therapy research
  • Pharmaceutical studies and practices
  • Lung Cancer Research Studies

Andrew D.J. Pearson has authored numerous papers in reputed journals. Some recent publications include:

  • "Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)", 2020, Cancers
  • "Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study", 2020, Journal of Clinical Oncology
  • "Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project", 2020, Journal of Clinical Oncology
  • "Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma", 2020, European Journal of Cancer
  • "ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients", 2020, European Journal of Cancer

The frequent co-authors in Pearson's collaborative network include:

  • Gilles Vassal
  • Lynley V. Marshall
  • Karsten Nysom
  • Nicole Scobie
  • Lucas Moreno

Publication venues that have frequently featured Pearson's research are:

  • European Journal of Cancer
  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • The Lancet Oncology
  • The Lancet Child & Adolescent Health

Best Publications

  • The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

    Susan L. Cohn;Andrew D.J. Pearson;Wendy B. London;Tom Monclair

  • The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

    Tom Monclair;Garrett M. Brodeur;Peter F. Ambros;Hervé J. Brisse

  • Advances in Risk Classification and Treatment Strategies for Neuroblastoma

    Navin R. Pinto;Mark A. Applebaum;Samuel L. Volchenboum;Katherine K. Matthay

  • β-Catenin Status Predicts a Favorable Outcome in Childhood Medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee

    David W. Ellison;Olabisi E. Onilude;Janet C. Lindsey;Meryl E. Lusher

  • Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project

    Hervé J. Brisse;M. Beth McCarville;Claudio Granata;K. Barbara Krug

  • International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

    PF Ambros;IM Ambros;GM Brodeur;M Haber

  • High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial.

    Andrew D. J. Pearson;C. Ross Pinkerton;Ian J. Lewis;John Imeson

  • Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.

    Evelyn Jaros;Robert H. Perry;L. Adam;Peter J. Kelly

  • The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.

    Teeara Berry;William Luther;Namrata Bhatnagar;Yann Jamin

  • Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

    Ruth Ladenstein;Ruth Ladenstein;Ulrike Pötschger;Andrew D J Pearson;Penelope Brock

  • Prognostic Significance of HER2 and HER4 Coexpression in Childhood Medulloblastoma

    Richard J. Gilbertson;Robert H. Perry;Peter J. Kelly;Andrew D. J. Pearson

  • Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

    Ruth Ladenstein;Ulrike Pötschger;Dominique Valteau-Couanet;Roberto Luksch

  • Surveillance and epidemiology of MRSA bacteraemia in the UK

    Alan P. Johnson;Andrew Pearson;Georgia Duckworth

  • Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

    Wendy B. London;Victoria Castel;Tom Monclair;Peter F. Ambros

  • Intestinal permeability in children with Crohn's disease and coeliac disease.

    A D Pearson;E J Eastham;M F Laker;A W Craft

  • Combined Histopathological and Molecular Cytogenetic Stratification of Medulloblastoma Patients

    Jayne M. Lamont;Charles S. McManamy;Andrew D. Pearson;Steven C. Clifford

  • Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

    Julie R Park;Rochelle Bagatell;Susan L Cohn;Andrew D Pearson

  • Criteria for evaluation of disease extent by 123 I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force

    K. K Matthay;B Shulkin;R Ladenstein;J Michon

  • Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin.

    Shapiro Rs;Chauvenet A;McGuire W;Pearson A

  • Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

    Ruth Ladenstein;T. Philip;C. Lasset;O. Hartmann

Frequent Co-Authors

Gilles Vassal
Gilles Vassal Institut Gustave Roussy
Susan L. Cohn
Susan L. Cohn University of Chicago
Wendy B. London
Wendy B. London Harvard University
Alan W. Craft
Alan W. Craft Newcastle University
Peter F. Ambros
Peter F. Ambros St Anna Children's Hospital
Paul Workman
Paul Workman Institute of Cancer Research
Chris Jones
Chris Jones Institute of Cancer Research
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Genevieve Laureys
Genevieve Laureys Ghent University Hospital
Suzanne A. Eccles
Suzanne A. Eccles Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn't always require a traditional MD. The healthcare field offers a variety of related online degrees and certifications that open doors to rewarding roles in patient care, health management, and administration.

Those interested in healthcare data and administration can explore HIM programs to learn about electronic health records and medical data management. If you're looking for a quick entry into the workforce, consider the medical billing and coding certification cost and benefits. This certification is a practical way to start a healthcare career with a flexible schedule.

For those with a nursing background, online nurse practitioner programs can provide advanced clinical skills and the opportunity for higher-level positions. Alternatively, if you already have a non-nursing bachelor’s degree, the cheapest online accelerated BSN programs can be a fast-track pathway into nursing.

Each of these online options allows you to begin or advance your healthcare career from anywhere, offering flexibility, affordability, and strong job prospects.

Best Scientists Citing Andrew D.J. Pearson

Trending Scientists

Recently Published Articles